comparemela.com

Page 5 - Drug Treatment Safety News Today : Breaking News, Live Updates & Top Stories | Vimarsana

FDA Warns AstraZeneca on Misleading Claims About COPD Drug

Claims that Breztri has been shown to reduce risk of death in COPD patients are not supported by clinical data, the agency says.

Drug administrationChronic obstructive pulmonary disease copdChronic obstructive pulmonary diseaseChronic obstructive lung diseaseClinical researchClinical trialsLinical studiesDrug treatment safetyHealthcare and medical technologyEalth and medical techEalth and med techEalth and medical technologyInhaled corticosteroidsIntranasal corticosteroidsNasal corticosteroidsBeta adrenergic

Drug Name Confusion: List of Problem Medications Grows

The Institute for Safe Medication Practices, which is focused on preventing medication errors, added 82 new drug pairs to its list of medicines requiring special safeguards to reduce error risk.

United statesNew yorkLetairis ambrisentanZolpidem ambienMary ann kliethermesCitalopram celexaDrug administrationDrug safety instituteNew york timesInstitute for safe medication practicesMedication safety best practices for community pharmacyJournal of the american pharmacists associationBrand institute in miamiAmerican society of healthHealthcare providers service organizationSafe medication practices

New Consensus on Managing Acetaminophen Poisoning

Experts trained in multiple relevant clinical specialties have developed a consensus statement on emergency management of acetaminophen poisoning.

Rocky mountainUnited statesRichardc dartUniversity of colorado school medicineRocky mountain poisonDrug safetyColorado schoolAcetaminophen toxicityClinical guidelinesPatient safetyDrug treatment safetyRug overdose

Pandemic Blamed for Failed Trial of Inhaled Antibiotic

Inhaled colistimethate sodium showed a large benefit in one trial but produced almost no effect in the other, a result attributed to the COVID pandemic.

New yorkUnited statesUnited kingdomComunidad autonoma de catalunaEva polverinoCharles haworthCambridge centre for lung infectionWorld bronchiectasisCambridge centreLung infectionRoyal papworth hospitalHospital clinic019 novel coronavirus019 ncovUhan coronavirusUman coronavirus hku1

FDA Approves Cantharidin for Treating Molluscum Contagiosum

The product is a drug-device combination that contains a formulation of cantharidin solution (0.7%), delivered topically via a single-use applicator.

Medscape professional networkMedscape professionalSkin and soft tissue infectionMolluscum contagiosumPain managementPain managementPatient safetyDrug treatment safetyUs food and drug administrationNited states food and drug administration

vimarsana © 2020. All Rights Reserved.